Herpesvirus medications

Last updated: September 12, 2024

Herpesvirus medications

B10

B10

Bacterial structure and functions
Staphylococcus epidermidis
Staphylococcus saprophyticus
Staphylococcus aureus
Streptococcus viridans
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Streptococcus agalactiae (Group B Strep)
Enterococcus
Inflammation
Wound healing
Sepsis
Abscesses
Neonatal sepsis
Thymus histology
Spleen histology
Lymph node histology
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Anergy, exhaustion, and clonal deletion
Vaccinations
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Common variable immunodeficiency
IgG subclass deficiency
Hyperimmunoglobulin E syndrome
Isolated primary immunoglobulin M deficiency
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Hereditary angioedema
Asplenia
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Glucocorticoids
Introduction to the lymphatic system
Skin histology
Skin anatomy and physiology
Hair, skin and nails
Burns: Clinical
DNA structure
DNA replication
Transcription of DNA
DNA damage and repair
Translation of mRNA
Zika virus
Herpes simplex virus
Herpesvirus medications
Epstein-Barr virus (Infectious mononucleosis)
Influenza virus
Poliovirus
Rubella virus
Parvovirus B19
Rotavirus
Norovirus
Adenovirus
Viral structure and functions
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Gastroenteritis
Bacterial epiglottitis
Helicobacter pylori
Neisseria gonorrhoeae
Varicella zoster virus
Food allergy
Anaphylaxis
Asthma
Immune thrombocytopenia
Autoimmune hemolytic anemia
Hemolytic disease of the newborn
Rheumatic heart disease
Myasthenia gravis
Graves disease
Pemphigus vulgaris
Serum sickness
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
Graft-versus-host disease
Contact dermatitis
Transplant rejection
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
Thymoma
Ruptured spleen
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Antituberculosis medications
Meningitis, encephalitis and brain abscesses: Clinical
Pneumonia
DNA synthesis inhibitors: Fluoroquinolones
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Monoclonal antibodies
Mycoplasma pneumoniae
Pneumonia: Pathology review
Haemophilus influenzae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Chlamydia pneumoniae
Meningitis
Neisseria meningitidis
Escherichia coli
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Shigella
Clostridium difficile (Pseudomembranous colitis)
Clostridium botulinum (Botulism)
Azoles
ELISA (Enzyme-linked immunosorbent assay)
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Blood groups and transfusions
Blood products and transfusion: Clinical
Anti-tumor antibiotics
Sexually transmitted infections: Clinical

Transcript

Watch video only

Anti-herpes medications are a group of antiviral agents that treat herpes infections including herpes simplex virus, or HSV, but they can also treat other viral infections like varicella zoster virus, or VZV, and cytomegalovirus, or CMV.

They act by inhibiting viral DNA synthesis and thus, inhibiting viral proliferation.

Alright, now let’s start with HSV, which infects skin and mucosal epithelial cells.

There are two types of HSV, HSV1 and HSV2.

Generally speaking, HSV1 tends to cause infections “above the waist” mostly involving the lips, or labia, which is referred to as herpes labialis, and the mouth and the gingiva, which is called gingivostomatitis.

In rare cases, HSV1 can spread to the esophagus, causing esophagitis, or to the central nervous system, causing meningitis or encephalitis, typically affecting the temporal lobe.

On the other hand, HSV2 tends to cause infections “below the waist” affecting the genital organs, which is referred to as herpes genitalis.

HSV can also pass from a mother to a baby usually when the baby passes through the infected maternal vaginal secretions and can cause severe neonatal infections.

The typical presentation of a herpes infection is clusters of small, painful, fluid-filled blisters, that ooze and ulcerate. They eventually heal after a few weeks.

However, HSV also infects the nearby sensory neurons, which aren’t destroyed, but instead, they become a permanent home for the herpes virus. This is referred to as the latent phase of the infection and is typically asymptomatic.

From time to time, the herpes virus from the sensory neurons make a few viral copies of itself which can get released and infect the epithelial cells.

Alright, now let’s move on to varicella zoster virus. VZV causes a primary infection called varicella or chickenpox, which is characterized by a rash on the scalp, face, and trunk that contains macules, papules, vesicles, and scabs at the same time.

Now, from the neurons in the skin, VZV travels retrogradely to the nerve ganglia, where it remains dormant.

Later on, if the immune system weakens, due to aging, stress, or immunosuppressive therapy, the virus can be reactivated.

It can then travel back up through the sensory nerves, anterogradely to the skin and cause an infection in the innervated dermatome - that’s called herpes zoster or shingles.

Now, let’s talk a bit about cytomegalovirus. CMV causes mononucleosis, commonly known as “mono,” which presents with sore throat, fever, lymphadenopathy, malaise, headache, and resolves over a few weeks.

Now, in immunocompromised individuals, CMV can cause more severe infections including pneumonia, esophagitis, and retinitis which can lead to vision loss.

CMV can also pass from a mother to a baby via the placenta causing a potentially life-threatening congenital infection.

Alright, now depending on their mechanism of action, anti-herpes medications can be divided into two categories: the guanosine analogs, and the viral DNA polymerase inhibitors.

Let’s start with the guanosine analogs which include acyclovir; medications that are similar to acyclovir such as valacyclovir, penciclovir, famciclovir, ganciclovir, and valganciclovir.

Once they’re inside an infected cell, they get phosphorylated to a monophosphate form by a viral enzyme, which is called viral kinase.

For example, acyclovir is converted to the acyclovir monophosphate by the viral thymidine kinase, while ganciclovir is initially phosphorylated by the enzyme UL-97 kinase, which is found in CMV infected cells.

Next, the monophosphate form is phosphorylated twice to the active triphosphate form by cellular enzymes.

This triphosphate form acts as a guanosine analog which means that it’s similar in structure with the normal guanosine nucleotide.

When this analog is inserted into the replicating viral DNA, it causes the growing DNA chain to terminate and DNA synthesis is halted.

Okay, now resistance to these medications can be developed if there is a mutated form of the viral kinase which won’t phosphorylate the medication.

Alright, now let’s move on to indications. Acyclovir is active against HSV and VZV.

When it’s used orally it’s only partially absorbed and so oral acyclovir is used for mild mucocutaneous lesions and genital lesions or for herpes prophylaxis in immunocompromised individuals such as individuals with AIDS.

Now, intravenous acyclovir is the treatment of more severe herpes infections, such as HSV encephalitis.

Acyclovir has no effect on latent forms of HSV and VZV.

Key Takeaways

Herpes medications are antiviral agents used to treat herpes infection. They mainly work by interfering with DNA replication of Herpes simplex viruses. Commonly prescribed herpes medications include acyclovir, cidofovir, foscarnet, and valacyclovir. Side effects include nephrotoxicity, electrolyte imbalances, headaches, hallucinations, and seizures.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir." Antimicrobial Agents and Chemotherapy (1986)
  5. "Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir" Drug Design, Development and Therapy (2016)
  6. "Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients" Transplant Infectious Disease (2018)
  7. "Antiviral Drug Resistance of Human Cytomegalovirus" Clinical Microbiology Reviews (2010)